BlackRock »

Conduit Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of Conduit Pharmaceuticals shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $50 74 0.68
2025-06-30 $204 74 2.76

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Conduit Pharmaceuticals

Citadel Advisors
Tower Research Capital
BlackRock

View all funds holding Conduit Pharmaceuticals